Angela Weiss | AFP | Getty Images
The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth quarter of this year.
Here’s what Walgreens reported for the three-month period ended Feb. 28 compared with what Wall Street was expecting, based on a survey of analysts by LSEG:
- Earnings per share: 63 cents adjusted vs. 53 cents expected
- Revenue: $38.59 billion vs. $38 billion expected
This story is developing. Please check back for updates.
Breaking News: Business,Health care industry,Pharmaceuticals,Biotech and Pharmaceuticals,Biotechnology,Business,Earnings,Walgreens Boots Alliance Inc,business news
#Walgreens #WBA #earnings